G

H

GROTE , H. J.

Last name: GROTE

First name: H. J.

January 1, 2021 (v1)

Journal article

Metadata-only

Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial

Guigay, Joël Lee, K. W. Patel, M. R.

Background Recurrent and/or metastatic (R/M) disease develops in approximately 65% of patients with squamous cell carcinoma of the head and neck (SCCHN) and is associated with a poor prognosis. Immune checkpoint inhibitors have proven effective in multiple tumor types, including R/M SCCHN. We report the efficacy and safety of avelumab...

Uploaded on: February 23, 2024